Dividends CalendarEarnings Calendar
ALVR

ALVR | Allovir Inc

41.65 -1.04 (-2.44%) 
Healthcare sector
Category: Healthcare
  • Industry: Biotechnology

Quick infos

    Trade prices

    • Volume:
    • Market Cap: 2.68B
    • Prev closed:
    • Open:
    • High:
    • Low:
    • 52 week low:
    • 52 week high:
    • Dividends:No Dividends

    Next ER: February 9, 2021 



    Top Stories (ALVR)

      Company Profile

      AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company?s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir?s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.

      Earnings History

      Date EPS / Forecast Revenue / Forecast
      June 2, 2021
      March 3, 2021
      November 10, 2020-0.58 / -0.33- / -
      September 2, 2020-4.43 / -0.31- / -
      July 6, 2020-0.34 / -165.0K / -Beat!
      view more

      Historical Data

      DatePriceOpenHighLowVolChangeER
      Jan 26, 2021 39.47 41.01
      41.86
      37.85
      		 138.44K -5.82%
      Jan 25, 2021 41.91 42.96
      43.88
      40.77
      		 114.40K -1.83%
      Jan 22, 2021 42.69 44.46
      44.46
      40.73
      		 178.41K -5.22%
      Jan 21, 2021 45.04 44.89
      45.92
      42.08
      		 171.55K 1.15%
      Jan 20, 2021 44.53 42.70
      44.91
      41.77
      		 107.59K 5.65%
      Jan 19, 2021 42.15 45.34
      45.94
      40.31
      		 263.53K -6.19%
      Jan 15, 2021 44.93 45.75
      46.80
      42.87
      		 144.93K -0.69%
      Jan 14, 2021 45.24 42.46
      45.44
      42.01
      		 156.10K 7.46%
      Jan 13, 2021 42.10 41.80
      43.32
      41.35
      		 94.63K 0.86%
      Jan 12, 2021 41.74 45.52
      45.52
      40.68
      		 215.45K -8.26%
      view more

      More profiles and info about the company

      • Employees:32

      This company doesn't provide a dividend.


      Talk about Allovir Inc below in comments section below.

      Do you think you'll buy? Do you already have active trades now?

      EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
      This profile is based on publicly available information and is intended to be informative in nature.

      Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




      Other ER on Feb 9, 2021 (Same day)

      twtr csco akam fox thc ncr pagp gt oi fmc wu cck 


      Jump to (Finance sites)

      Google     
               

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 




      Recommended Books

      Technical Analysis For Dummies
      Buy on Amazon

      Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

      A simple, straightforward guide to the fundamentals of technical analysis